Microdosing with psilocybin mushrooms: a double-blind placebo-controlled study
Abstract The use of low sub-perceptual doses of psychedelics (“microdosing”) has gained popularity in recent years. Although anecdotal reports claim multiple benefits associated with this practice, the lack of placebo-controlled studies severely limits our knowledge of microdosing and its effects. M...
Main Authors: | Federico Cavanna, Stephanie Muller, Laura Alethia de la Fuente, Federico Zamberlan, Matías Palmucci, Lucie Janeckova, Martin Kuchar, Carla Pallavicini, Enzo Tagliazucchi |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2022-08-01
|
Series: | Translational Psychiatry |
Online Access: | https://doi.org/10.1038/s41398-022-02039-0 |
Similar Items
-
Baseline Power of Theta Oscillations Predicts Mystical-Type Experiences Induced by DMT in a Natural Setting
by: Enzo Tagliazucchi, et al.
Published: (2021-11-01) -
Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
by: Joseph M. Rootman, et al.
Published: (2022-06-01) -
The Effectiveness of Microdosed Psilocybin in the Treatment of Neuropsychiatric Lyme Disease: A Case Study
by: Kinderlehrer DA
Published: (2023-03-01) -
Author Correction: Psilocybin microdosers demonstrate greater observed improvements in mood and mental health at one month relative to non-microdosing controls
by: Joseph M. Rootman, et al.
Published: (2022-07-01) -
The Varieties of the Psychedelic Experience: A Preliminary Study of the Association Between the Reported Subjective Effects and the Binding Affinity Profiles of Substituted Phenethylamines and Tryptamines
by: Federico Zamberlan, et al.
Published: (2018-11-01)